Wikidata

(Q63571435)

English

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

clinical trial

In more languages

Statements

short name
CHROMA (English)
0 references
title
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (English)
0 references
medical condition
macular degeneration
0 references
atrophy
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
Italy
0 references
Mexico
0 references
Netherlands
0 references
Peru
0 references
Poland
0 references
Slovakia
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
18 September 2014
0 references
end time
29 January 2018
0 references
number of participants
906
0 references
minimum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63571435&oldid=1857251846"